Your prediction
Pros and Cons of Predictmedix Ai Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform
Adaptive “digital brain” designed to cut risk, cost and timelines in the $70-billion clinical-trials market1
TORONTO, October 1, 2025 — Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA:
Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader
Clinically validated SmartHealth AI Stations anchor expansion into Clinical-Trial Optimization and Consumer Digital Health, creating multiple recurring-revenue opportunities
TORONTO,